Immediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand-valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR as necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Barium and Related Compounds/
Basic treatment: Establish a patent airway (oropharyngeal or nasopharyngeal airway, if needed). Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if necessary. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with 0.9% saline (NS) during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Do not attempt to neutralize because of exothermic reaction. Cover skin burns with dry sterile dressings after decontamination ... . /Barium and Related Compounds/
Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious or is in severe respiratory distress. Monitor cardiac rhythm and treat arrhythmias if necessary ... . Start IV administration of 0.9% saline (NS) or lactated Ringer's (LR) /SRP: "To keep open", minimal flow rate/. For hypotension with signs of hypovolemia, administer fluid cautiously Watch for signs of fluid overload. For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Treat seizures with diazepam or lorazepam ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Barium and Related Compounds/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
非人类毒性摘录
实验室动物:急性暴露/对兔子的皮肤刺激:阴性。
/LABORATORY ANIMALS: Acute Exposure/ Skin irritation to rabbits: negative.
/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ Two hundred and fifty 3-week-old Osborne-Mendel rats divided into 5 groups of 50 rats each, and each group equally divided by sex, were started on a 2-year feeding experiment on D & C Red No. 10 which was mixed into the diet at levels of 1%, 0.25%, 0.05%, 0.01%, and 0% (controls) and fed ad libitum. The color had no apparent effect on the growth rate of test rats. Percentage of rats surviving on the 2-year test was increased by the addition of the color to the diet. Slight to moderate splenic enlargement was noted in 1% and 0.25% feeding level rats. Grossly 42% of the rats had pneumonia, 17% had nephritis, 17% had pituitary lesions, and 43% of the females had mammary tumors. Other incidental gross pathology randomly distributed among these 250 rats included lymphosarcoma in 7 rats, subcutaneous tumors in 5 males, endometrial sarcomas in 4 females, thyroid tumors in 4 rats, testicular tumors in 3, hepatic tumors in 2, abdominal lipoma in 1, leukemia in 1, ovarian tumor in 1, cystic ovaries in 5, ovarian abscesses in 2, and 1 rat each with a splenic infarct, a large abdominal hematoma, and a foot-pad granuloma. Approximately 800 tissue sections from these 250 rats were prepared for microscopic study. Histopathology attributable to D & C Red No. 10 toxicity occurred only in the spleen and bone marrow. Since survival of the test animals is considered to be more important to these animals than their slight to moderate splenic and bone marrow hyperplasia, it is apparent that D & C Red No. 10 had a beneficial effect in this experiment. However, because of the undesirable side effects of splenomegaly and bone-marrow hyperplasia at the 1% and 0.25% feeding levels, the 0.05% level should be considered the "no-effect" level. / D and C Red No. 10 (monosodium salt of 2-(2-hydroxy-1-naphthylazo)-1-naphthalenesulfonic acid)/